Share this article
Share this article
ALBANY, N.Y., June 9, 2021 /PRNewswire/ Tuberculosis testing has advanced continuously over the years to help in the diagnosis of TB and occupies a key role in preventing its transmission. Adoption of infection control practices has propelled healthcare providers in collaboration with government to identify at-risk populations. The high mortality of pulmonary tuberculosis has led to remarkable advancements in culture-based tests.
Tests to identify Mycobacterium tuberculosis in the body, a gold standard for testing, has been extensively helpful in reducing the burden of active tuberculosis. Advances in such tests are expanding the avenue in the tuberculosis testing market. However, Mantoux TST needs a follow-up tests, and has shown limited success in confirming TB disease in the individual. The lack of TST antigen is a key factor for its limited efficacy in developing world.